Meridian Clinical Trials Paul-TanPiengco

Chairman & CEO of VITRUVIAN BioMedical, Inc. which is developing an Alzheimer Disease Blood Test and Therapeutic Vaccine targeting both ABeta and TAU. First company founded was Wadley Biosciences/LPL which was a joint venture between Wadley Institutes and Phillips Petroleum with focus on cancer and infectious disease, 1987-1992. The second company founded was Cytoclonal Pharmaceutics, which went public with an IPO in 1995, and entered into a licensing agreement with Bristol Myers on Taxol production, and was merged to create OPKO Health. Former Chairman & CEO of HemoBioTech, Inc., developing HemoTech as viable substitute for human red blood cells.

Speaker Details